Literature DB >> 9203731

Certification of the eradication of indigenous transmission of wild poliovirus in the Americas.

F C Robbins1, C A de Quadros.   

Abstract

In May 1985, the Pan American Health Organization launched an initiative to interrupt indigenous transmission of the wild poliovirus from the Western Hemisphere by the year 1990. The strategy to achieve this goal was based on the maintenance of high levels of immunity in the population at risk and the establishment of a surveillance system to detect polio cases and respond promptly with control measures. On 23 August 1991, a 2-year-old boy with acute flaccid paralysis due to wild poliovirus was detected in Junin, Peru, the last isolation of such a virus in the entire Western Hemisphere. In 1990, an International Commission for the Certification of Eradication of Poliomyelitis Eradication (ICCPE) was established by the Pan American Health Organization to eventually determine if transmission was interrupted. After 3 years of follow-up and review of surveillance data, the ICCPE declared that wild poliovirus transmission had been interrupted in the Americas.

Entities:  

Mesh:

Year:  1997        PMID: 9203731     DOI: 10.1093/infdis/175.supplement_1.s281

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Perspectives from the global poliomyelitis eradication initiative.

Authors:  H F Hull; C de Quadros; J Bilous; G Oblapenko; J Andrus; R Aslanian; H Jafari; J M Bele; R B Aylward
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

2.  A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.

Authors:  Minetaro Arita; Shuang-Li Zhu; Hiromu Yoshida; Tetsuo Yoneyama; Tatsuo Miyamura; Hiroyuki Shimizu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Haiti Poliovirus Environmental Surveillance.

Authors:  Angela D Coulliette-Salmond; Mary M Alleman; Pierre Wilnique; Gloria Rey-Benito; Hanen Belgasmi Wright; Jessica Wielgus Hecker; Stacey Miles; Silvia Peñaranda; Donald Lafontant; Salomon Corvil; Jeannot Francois; Emmanuel Rossignol; Magalie Stanislas; Edmond Gue; Papa C Faye; Christina J Castro; Alexander Schmidt; Terry Fei Fan Ng; Cara C Burns; Everardo Vega
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 4.  Enteroviruses as agents of emerging infectious diseases.

Authors:  G Palacios; M S Oberste
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

5.  Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.

Authors:  Gabriel Trueba; Vishali Jeyaseelan; Lazaro Lopez; Bernardo A Mainou; Yiting Zhang; Alvaro Whittembury; Alfredo Jose Olmedo Valarezo; Gonzalo Baquero; Rosa Romero de Aguinaga; Lucia Jeannete Zurita Salinas; Maria Gabriela Santacruz Mancheno; Diana Elizabeth Medina Chacho; Emmanuelle Quentin; Ana Elena Chevez; Gloria Rey-Benito; Ondrej Mach
Journal:  Lancet Reg Health Am       Date:  2022-07

Review 6.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

7.  Statement on poliovirus and the international traveller.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2014-07-10

Review 8.  Global Polio Eradication - Way Ahead.

Authors:  Sunil Bahl; Pankaj Bhatnagar; Roland W Sutter; Sigrun Roesel; Michel Zaffran
Journal:  Indian J Pediatr       Date:  2018-01-05       Impact factor: 1.967

9.  Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.

Authors:  Cristina Pedreira; Elizabeth Thrush; Barbara Jauregui
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

10.  The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks.

Authors:  Ousmane M Diop; Olen M Kew; Esther M de Gourville; Mark A Pallansch
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.